Amgen Aktie - AMGN

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

284,02

Gebot

282,03

Fragen

285,09

Volumen

181

0,00 Tagesbereich 0,00

253,30 52-Wochen-Bereich 346,85

Marktkapitalisierung

152,67B

Handelsende

284,02

Handelsbeginn

Letzte Trade

284

Letzter Handelszeitpunkt

11:35:56

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

3.816.757

Ausgegebene Aktien

537.532.723

Dividendenrendite

3.35%

Kurs-Gewinn-Verhältnis

22,73

Gewinn pro Aktie (EPS)

12,5

Erlöse

28,19B

Nettogewinn

6,72B

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory disease... Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira). Mehr anzeigen

Sektor

Biological Pds,ex Diagnstics

Branche

Biological Pds,ex Diagnstics

Website

www.amgen.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Amgen Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker AMGN. The last closing price for Amgen was US$284,02. Over the last year, Amgen shares have traded in a share price range of US$ 253,30 to US$ 346,85.

Amgen currently has 537.532.723 shares in issue. The market capitalisation of Amgen is US$152,67 billion. Amgen has a price to earnings ratio (PE ratio) of 22.73.

Gesamtfluss

Bullisch

Nettoprämie

1M

Calls / Puts

400,00%

Käuf. / Verkä.

130,00%

OTM / ITM

92,31%

Sweeps

0,00%

EUROPEAN COMMISSION APPROVES BLINCYTO® IN PHILADELPHIA CHROMOSOME-NEGATIVE CD19-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN THE CONSOLIDATION PHASE

EUROPEAN COMMISSION APPROVES BLINCYTO® IN PHILADELPHIA CHROMOSOME-NEGATIVE CD19-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN THE CONSOLIDATION PHASE PR Newswire THOUSAND OAKS...

FDA APPROVES LUMAKRAS® (SOTORASIB) IN COMBINATION WITH VECTIBIX® (PANITUMUMAB) FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER

FDA APPROVES LUMAKRAS® (SOTORASIB) IN COMBINATION WITH VECTIBIX® (PANITUMUMAB) FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER PR Newswire THOUSAND OAKS, Calif., Jan. 17, 2025...

AMGEN TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

AMGEN TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PR Newswire THOUSAND OAKS, Calif., Jan. 8, 2025 THOUSAND OAKS, Calif., Jan. 8, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will...

AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND

AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND PR Newswire THOUSAND OAKS, Calif., Dec. 10, 2024 THOUSAND OAKS, Calif., Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its...

BLINCYTO® (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN NEWLY DIAGNOSED PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)

BLINCYTO® (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN NEWLY DIAGNOSED PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) PR...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	7.76	2.80894809238	276.26	285.69	273.5	2639961	281.23120424	CS
4	24.075	9.26157456385	259.945	285.69	257.05	3070784	270.65369865	CS
12	-38.45	-11.9235897913	322.47	328.25	253.3	3816757	276.19743691	CS
26	-47.53	-14.3356959735	331.55	340.89	253.3	2736730	295.30926044	CS
52	-31.98	-10.1202531646	316	346.85	253.3	2704394	295.45040137	CS
156	56.04	24.5811036056	227.98	346.85	211.73	2710625	265.40817851	CS
260	65.2565	29.8297019384	218.7635	346.85	177.05	2711386	250.90204064	CS

AMGN - Frequently Asked Questions (FAQ)

What is the current Amgen share price?

The current share price of Amgen is US$ 284,02

How many Amgen shares are in issue?

Amgen has 537.532.723 shares in issue

What is the market cap of Amgen?

The market capitalisation of Amgen is USD 152,67B

What is the 1 year trading range for Amgen share price?

Amgen has traded in the range of US$ 253,30 to US$ 346,85 during the past year

What is the PE ratio of Amgen?

The price to earnings ratio of Amgen is 22,73

What is the cash to sales ratio of Amgen?

The cash to sales ratio of Amgen is 5,42

What is the reporting currency for Amgen?

Amgen reports financial results in USD

What is the latest annual turnover for Amgen?

The latest annual turnover of Amgen is USD 28,19B

What is the latest annual profit for Amgen?

The latest annual profit of Amgen is USD 6,72B

What is the registered address of Amgen?

The registered address for Amgen is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808

What is the Amgen website address?

The website address for Amgen is www.amgen.com

Which industry sector does Amgen operate in?

Amgen operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
TDTHTrident Digital Tech Holdings Ltd	US$ 1,96 (106,32%)	5,47M
EDRYEuroDry Ltd	US$ 18,34 (63,75%)	8
WVVIWillamette Valley Vineyards Inc	US$ 9,21 (60,17%)	250
OPOFOld Point Financial Corporation	US$ 39,05 (59,98%)	4
CCECCapital Clean Energy Carriers Corporation	US$ 30,40 (59,00%)	12
NYAXNAYAX Ltd	US$ 17,01 (-56,16%)	6
LNSRLENSAR Inc	US$ 5,01 (-53,74%)	216
CLRCClimateRock	US$ 6,00 (-49,46%)	277
CEPOCantor Equity Partners I Inc	US$ 6,01 (-40,20%)	1
ENVBEnveric Biosciences Inc	US$ 2,36 (-39,49%)	98,19k
CLEUChina Liberal Education Holdings Ltd	US$ 0,1595 (7,62%)	13,3M
KITTNauticus Robotics Inc	US$ 2,33 (49,36%)	9,77M
TDTHTrident Digital Tech Holdings Ltd	US$ 1,96 (106,32%)	5,47M
ORKTOrangeKloud Technology Inc	US$ 1,615 (17,88%)	3,42M
BHATBlue Hat Interactive Entertainment Technology	US$ 0,0366 (-8,50%)	2,09M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Amgen Inc (AMGN) Börsenkurse

Amgen Inc (AMGN)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Amgen Inc

Option-Flow Amgen (AMGN)

Gesamtfluss

Bullisch

Nettoprämie

1M

Calls / Puts

400,00%

Käuf. / Verkä.

130,00%

OTM / ITM

92,31%

Sweeps

0,00%

AMGN Neueste Nachrichten

AMGN - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen